Schreder Martin

8PUBLICATIONS
35CO-AUTHORS
Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Molecular targetsCross-sectional analysisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 13, 2026
Plerixafor and G-CSF Versus Placebo and G-CSF in Moderately Mobilizing Patients With Multiple Myeloma to Optimize Hematopoietic Stem Cell Collection Results (OPTIMIZE).

|Sep 11, 2024
Association of ADAM family members with proliferation signaling and disease progression in multiple myeloma.

Marietheres Evers, Thorsten Stühmer, Martin Schreder

|Oct 29, 2023
CTPS1 is a novel therapeutic target in multiple myeloma which synergizes with inhibition of CHEK1, ATR or WEE1.

Christina Pfeiffer, Alexander M Grandits, Hélène Asnagli

|Mar 11, 2023
Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMT.

Lisa Pleyer, Sonja Heibl, Christoph Tinchon

|Sep 28, 2021
The Agony of Choice-Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond.

Irene Strassl, Martin Schreder, Normann Steiner

|Sep 03, 2021
Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma.

Arnold Bolomsky, Juho J Miettinen, Alina Malyutina

Pageof 2

Frequent Collaborators

2 joint publications

Ralf Christian Bargou

2 joint publications

Ellen Leich

2 joint publications

Hermann Einsele

2 joint publications

Regina Ebert